These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7693794)

  • 1. [Bowel resections in cancers of the ovary ].
    Kauffmann P; Le Bouëdec G; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):501-8. PubMed ID: 7693794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bowel resection on survival in advanced epithelial ovarian cancer.
    Jaeger W; Ackermann S; Kessler H; Katalinic A; Lang N
    Gynecol Oncol; 2001 Nov; 83(2):286-91. PubMed ID: 11606086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent intraabdominal cancer with intestinal obstruction.
    Averbach AM; Sugarbaker PH
    Int Surg; 1995; 80(2):141-6. PubMed ID: 8530231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Repeated liver resections for metastases from colorectal carcinoma: the experience of 23 cases].
    Nicoli N; Marchiori L; Mangiante G; Bortolasi L; Dal Dosso I; Aurola PP; Delaini GG; Serio G
    Chir Ital; 1994; 46(1):37-44. PubMed ID: 8025969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the index operation influence the course and outcome of adhesive intestinal obstruction?
    Matter I; Khalemsky L; Abrahamson J; Nash E; Sabo E; Eldar S
    Eur J Surg; 1997 Oct; 163(10):767-72. PubMed ID: 9373228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
    Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of P-32 in stage III epithelial carcinoma of the ovary.
    Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
    Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
    Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid carcinoma with tracheal or esophageal involvement: limited or maximal surgery?
    Mellière DJ; Ben Yahia NE; Becquemin JP; Lange F; Boulahdour H
    Surgery; 1993 Feb; 113(2):166-72. PubMed ID: 8430364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of progressive or recurrent malignant ovarian tumors].
    Teufel G; Nicolai M; Aisslinger U; Simonis H; Meerpohl HG; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):186-93. PubMed ID: 1711489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
    Sun T; Feng Y; Zhu Y; Zheng Y
    Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.